Molecular Testing Labs™ is a CLIA certified and CAP accredited testing laboratory that specializes in the cutting edge field of Molecular Genetics. Genetic testing has progressed well past the early days of counting chromosomes. It has extended its usefulness and applicability well beyond comparing DNA signatures, as is frequently seen in forensic work and crime dramas on TV and in the movies.
The science of molecular genetics uses molecular biology to identify information coded into the genes of a specific individual and how this information is expressed in that individual. The Human Genome Project, initiated in 1990, was completed in 2003. Since that time, thousands of individual genes have been identified.
Molecular Testing Labs™ provides genotyping data for mutations in genes proven to have an impact on patient health and quality of life. Pharmacogenetics technology has now provided us the tools and equipment to look at the individual base pairs of DNA, which are the molecules that make up DNA and can vary significantly between individuals. This process has been automated to the point where it is commercially available for many of the genes that have proven to be important.
Molecular genetic tests can yield a broad scope of information about an individual. This includes not only diagnostic information to determine if an individual has a genetically determined disorder, it also provides a way for healthcare providers to assess how each individual will respond to a large number of commonly prescribed medications, supplements and various environmental substances. The test results provide a window into an individual’s distinct pharmacokinetics. It is even possible to look at the genetic signature of many viruses and bacteria to definitively identify certain types of infections such as Human Papilloma Virus (HPV) and Herpes Simplex Virus 1 & 2 (HSV 1 & 2)
Molecular Testing Labs™ is at the forefront of this exciting new field. We offer an efficient and effective way to customize your healthcare and accept most insurance plans. We offer molecular genetic testing of a wide variety of genes that have been identified as having a significant clinical impact. As more genes are identified and tests developed to genotype individuals for those genes, we will continue to expand our offerings in order to remain as the pioneered and lead laboratory in Pharmacogenetics, Pharmacogenomics, and Pharmacokinetics.